Literature DB >> 28956527

One year in review 2017: novelties in the treatment of rheumatoid arthritis.

Francesco Ferro1, Elena Elefante2, Nicoletta Luciano2, Rosaria Talarico2, Monica Todoerti3.   

Abstract

Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and quality of life. The present review is aimed at providing a critical analysis of the recent literature on the novelties in the treatment of RA, with a particular focus on the most relevant studies published over the last year.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28956527

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  18 in total

1.  Analysis of PD-1 and Tim-3 expression on CD4+ T cells of patients with rheumatoid arthritis; negative association with DAS28.

Authors:  Zohreh Koohini; Hadi Hossein-Nataj; Maryam Mobini; Aref Hosseinian-Amiri; Alireza Rafiei; Hossein Asgarian-Omran
Journal:  Clin Rheumatol       Date:  2018-04-07       Impact factor: 2.980

2.  Anti-inflammatory effect of omega unsaturated fatty acids and dialysable leucocyte extracts on collagen-induced arthritis in DBA/1 mice.

Authors:  Pamela I Pérez-Martínez; Oscar Rojas-Espinosa; Víctor G Hernández-Chávez; Patricia Arce-Paredes; Sergio Estrada-Parra
Journal:  Int J Exp Pathol       Date:  2020-05-27       Impact factor: 1.925

3.  Combined atorvastatin and pentoxifylline in ameliorating inflammation induced by complete Freund's adjuvant.

Authors:  Sahar Etemadi; Seyyed Meysam Abtahi Froushani; Seyyed Mohammad Hashemi Asl; Alireza Mahmoudian
Journal:  Inflammopharmacology       Date:  2022-04-15       Impact factor: 4.473

4.  Real-life data of survival and reasons for discontinuation of biological disease-modifying drugs 'in' rheumatoid arthritis.

Authors:  Ana Paula Monteiro Gomides; Cleandro Pires de Albuquerque; Ana Beatriz Vargas Santos; Manoel Barros Bértolo; Paulo Louzada Júnior; Rina Dalva Neubarth Giorgi; Sebastião Cezar Radominski; Maria Fernanda B Resende Guimarães; Karina Rossi Bonfiglioli; Maria de Fátima Lobato da Cunha Sauma; Ivânio Alves Pereira; Claiton Viegas Brenol; Licia Maria Henrique da Mota; Geraldo da Rocha Castelar Pinheiro
Journal:  Int J Clin Pharm       Date:  2020-10-21

5.  Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry.

Authors:  Leslie R Harrold; Ying Shan; Sabrina Rebello; Neil Kramer; Sean E Connolly; Evo Alemao; Sheila Kelly; Joel M Kremer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2020-05-24       Impact factor: 2.631

6.  Comparative efficacy, safety and cost of oral Chinese patent medicines for rheumatoid arthritis: a Bayesian network meta-analysis.

Authors:  Dan Zhang; Jin-Tao Lyu; Bing Zhang; Xiao-Meng Zhang; Hao Jiang; Zhi-Jian Lin
Journal:  BMC Complement Med Ther       Date:  2020-07-06

7.  Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis.

Authors:  Ronan O'Dwyer; Marina Kovaleva; Jiquan Zhang; John Steven; Emma Cummins; Deborah Luxenberg; Alfredo Darmanin-Sheehan; Miguel F Carvalho; Matthew Whitters; Kenneth Saunders; Caroline J Barelle
Journal:  J Immunol Res       Date:  2018-10-17       Impact factor: 4.818

8.  Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis.

Authors:  Jing Jin; Ming Ji; Rong Fu; Mingjin Wang; Nina Xue; Qiong Xiao; Jingpin Hu; Xiaojian Wang; Fangfang Lai; Dali Yin; Xiaoguang Chen
Journal:  Front Pharmacol       Date:  2019-09-19       Impact factor: 5.810

9.  Galectin-1, -4, and -7 Were Associated with High Activity of Disease in Patients with Rheumatoid Arthritis.

Authors:  Kamila de Melo Vilar; Michelly Cristiny Pereira; Andrea Tavares Dantas; Moacyr Jesus Barreto de Melo Rêgo; Ivan da Rocha Pitta; Claudia Diniz Lopes Marques; Rafaela Silva Guimarães Gonçalves; Laurindo Ferreira da Rocha Júnior; Ângela Luzia Branco Pinto Duarte; Maira Galdino da Rocha Pitta
Journal:  Autoimmune Dis       Date:  2019-07-22

Review 10.  Natural Plant Extracts and Compounds for Rheumatoid Arthritis Therapy.

Authors:  Xiangyu Zhao; Young-Rok Kim; Yunhui Min; Yaping Zhao; Kyoungtag Do; Young-Ok Son
Journal:  Medicina (Kaunas)       Date:  2021-03-15       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.